Global Biomimetic Cryoprotectants Industry Growth and Trends Forecast to 2032

Biomimetic cryoprotectants are specialized chemical formulations that regulate ice nucleation, crystal growth, morphology, and recrystallization during the freezing, cryogenic storage, and thawing of living cells and biological tissues. Their active components reproduce selected ice regulating functions of natural antifreeze proteins and other cold adapted biological systems through molecular structures engineered to interact with ice surfaces and the surrounding aqueous phase. Commercially relevant materials include synthetic antifreeze peptoids, ice recrystallization inhibiting small molecules, modified polyvinyl alcohol, amphiphilic polymers, and polyampholytes such as carboxylated polylysine. Depending on molecular chemistry and formulation, these compounds modify ice nucleation behavior, inhibit crystal growth, restrict recrystallization during thermal fluctuations and warming, or suppress residual ice formation in vitrification systems. Their interactions at the ice and water interface can limit mechanical injury to cellular membranes, reduce damage associated with extracellular ice growth and osmotic stress, and preserve cellular integrity and functional recovery after thawing. Commercial products are supplied primarily as ready to use aqueous cryopreservation media and concentrated cryoprotectant additives, incorporating ice regulating molecules with selected buffers, electrolytes, sugars, polyols, and other formulation components. Certain formulations eliminate dimethyl sulfoxide (DMSO), serum, and animal derived proteins, while others combine biomimetic ice control agents with conventional permeating cryoprotectants to address complementary mechanisms of freezing injury. The defining technical characteristic is the demonstrated ice regulating function of the active formulation, which distinguishes these products from conventional preservation solutions relying exclusively on freezing point depression, osmotic adjustment, or increased solution viscosity. Commercial applications include cryopreservation of hematopoietic stem cells, mesenchymal stem cells, induced pluripotent stem cells, immune cells, engineered cellular therapeutics, reproductive cells, embryos, and biological specimens maintained in research and biobanking operations. Additional applications involve reproductive medicine, livestock breeding, tissue engineering, and experimental preservation of complex tissues and organs. Clinical cell manufacturing and laboratory biobanking constitute established commercial use environments, while whole organ cryopreservation remains at an earlier stage of technical development and commercialization.
Product & engineering
Understand the product.
Biomimetic cryoprotectants are specialized chemical formulations that regulate ice nucleation, crystal growth, morphology, and recrystallization during the freezing, cryogenic storage, and thawing of living cells and biological tissues. Their active components reproduce selected ice regulating functions of natural antifreeze proteins and other cold adapted biological systems through molecular structures engineered to interact with ice surfaces and the surrounding aqueous phase. Commercially relevant materials include synthetic antifreeze peptoids, ice recrystallization inhibiting small molecules, modified polyvinyl alcohol, amphiphilic polymers, and polyampholytes such as carboxylated polylysine. Depending on molecular chemistry and formulation, these compounds modify ice nucleation behavior, inhibit crystal growth, restrict recrystallization during thermal fluctuations and warming, or suppress residual ice formation in vitrification systems. Their interactions at the ice and water interface can limit mechanical injury to cellular membranes, reduce damage associated with extracellular ice growth and osmotic stress, and preserve cellular integrity and functional recovery after thawing. Commercial products are supplied primarily as ready to use aqueous cryopreservation media and concentrated cryoprotectant additives, incorporating ice regulating molecules with selected buffers, electrolytes, sugars, polyols, and other formulation components. Certain formulations eliminate dimethyl sulfoxide (DMSO), serum, and animal derived proteins, while others combine biomimetic ice control agents with conventional permeating cryoprotectants to address complementary mechanisms of freezing injury. The defining technical characteristic is the demonstrated ice regulating function of the active formulation, which distinguishes these products from conventional preservation solutions relying exclusively on freezing point depression, osmotic adjustment, or increased solution viscosity. Commercial applications include cryopreservation of hematopoietic stem cells, mesenchymal stem cells, induced pluripotent stem cells, immune cells, engineered cellular therapeutics, reproductive cells, embryos, and biological specimens maintained in research and biobanking operations. Additional applications involve reproductive medicine, livestock breeding, tissue engineering, and experimental preservation of complex tissues and organs. Clinical cell manufacturing and laboratory biobanking constitute established commercial use environments, while whole organ cryopreservation remains at an earlier stage of technical development and commercialization.
Selected research
Industry Growth & Trends
Global Biomimetic Cryoprotectants Industry Growth and Trends Forecast to 2032
MARKET AT A GLANCE
Scale & outlook
- 2026
- 4.58USD million
- 2032
- 15.2USD million
Select a bar to inspect its value.
Source: APO Research, Inc.
Market perspective
According to APO Research, Inc, the global biomimetic cryoprotectants market was valued at approximately USD 3.46 million in 2025 and is projected to reach USD 4.58 million in 2026 and USD 15.2 million by 2032, representing a compound annual growth rate of 22.13% from 2026 to 2032. Market expansion is primarily associated with the commercial adoption of ice regulating cryopreservation formulations in cell therapy manufacturing, stem cell banking, immune cell processing, and biological sample preservation. Unlike conventional formulations dependent primarily on permeating cryoprotectants, biomimetic systems employ synthetic ice regulating molecules to control crystal growth and recrystallization during freezing and warming. Commercial sales comprise formulated cryopreservation media and separately supplied ice inhibiting additives. Consumption depends on the number of manufacturing and banking batches, preservation volume per batch, and frequency of freezing operations. Revenue is influenced by formulation complexity, the concentration of specialized active ingredients, manufacturing requirements, and the proportion of qualified products supplied for clinical manufacturing applications.
The United States and China are important centers of commercial product development and manufacturing. X-Therma received FDA acceptance of a Drug Master File for its XT-Thrive cryopreservation medium in April 2024 and announced GMP commercial readiness at its Hercules, California, manufacturing facility in May 2024. The company's synthetic peptoid technology enables chemically defined formulations without DMSO, serum, or proteins, addressing the processing and formulation requirements of cell therapy developers. In China, CellStore Biotechnology operates manufacturing facilities in Beijing and Dongguan, including a reported 1,000 m² GMP manufacturing workshop. Its ice controlling formulations cover stem cells, immune cells, and biological specimens. The CS-AT-D2 immune cell medium combines 10% DMSO with ice controlling materials, illustrating the continued commercial relevance of formulations that integrate conventional cryoprotectants with molecular ice regulation. Product selection depends on cell type, functional recovery after thawing, manufacturing compatibility, and the qualification requirements of individual customers.
Industry commercialization remains dependent on product specific development and customer adoption. BioLife Solutions acquired PanTHERA CryoSolutions in April 2025, gaining access to KryoAegis ice recrystallization inhibitor technology introduced in March 2024. Repligen completed its acquisition of BioLife Solutions in October 2026, expanding the commercial resources available to the combined biopreservation business. PanTHERA's second generation ice recrystallization inhibitor technology remained under development in 2026, with commercial contribution dependent on subsequent qualification and adoption. In Japan, BMG supplies StemCell Keep for research applications involving embryonic and induced pluripotent stem cells, reflecting the established but relatively specialized demand for advanced vitrification formulations. Through 2032, incremental market revenue is expected to arise principally from increased cell manufacturing activity, repeated purchases of qualified cryopreservation media, and broader adoption of specialized formulations in research and biobanking. Clinical process validation, formulation costs, and established DMSO based alternatives will continue to constrain the pace of substitution. Complex tissue and whole organ cryopreservation are expected to remain smaller commercial applications during the forecast period.
Full market overview
Report Scope
This report provides a structured, data-driven view of the global Biomimetic Cryoprotectants market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Biomimetic Cryoprotectants market size, estimates, and forecasts are presented in terms of sales volume (L) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Biomimetic Cryoprotectants market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Biomimetic Cryoprotectants.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading manufacturers in the global Biomimetic Cryoprotectants market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Biomimetic Cryoprotectants Market by Company
- CellStore Biotechnology
- X-Therma
- Repligen
- BMG
- 21st Century Medicine
Biomimetic Cryoprotectants Segment by Type
- Cryopreservation Media
- Cryoprotectant Additives
Biomimetic Cryoprotectants Segment by Application
- Cell Therapy
- Research & Biobanking
- Assisted Reproduction
- Tissue & Organ Preservation
- Livestock Breeding
Biomimetic Cryoprotectants Segment by Region
- North America
- United States
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Spain
- Netherlands
- Switzerland
- Sweden
- Poland
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Australia
- Taiwan
- Southeast Asia
- South America
- Brazil
- Argentina
- Chile
- Colombia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Türkiye
- GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
- This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Biomimetic Cryoprotectants market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
- This report will help stakeholders to understand the global industry status and trends of Biomimetic Cryoprotectants and provides them with information on key market drivers, restraints, challenges, and opportunities.
- This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
- This report stays updated with novel technology integration, features, and the latest developments in the market.
- This report helps stakeholders to gain insights into which regions to target globally.
- This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Biomimetic Cryoprotectants.
- This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
- Chapter 1: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
- Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
- Chapter 3: Detailed analysis of Biomimetic Cryoprotectants manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
- Chapter 4: Sales, revenue of Biomimetic Cryoprotectants in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
- Chapter 5: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
- Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
- Chapters 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
- Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
- Chapter 13: Concluding Insights of the report.
More report detail
Tables and figures
List of Tables
- Table 1. Major Company of Cryopreservation Media
- Table 2. Major Company of Cryoprotectant Additives
- Table 3. Global Biomimetic Cryoprotectants Sales by Type (2021 VS 2025 VS 2032) & (US$ Million)
- Table 4. Global Biomimetic Cryoprotectants Sales by Type (2021-2026) & (L)
- Table 5. Global Biomimetic Cryoprotectants Sales Market Share in Volume by Type (2021-2026)
- Table 6. Global Biomimetic Cryoprotectants Sales by Type (2021-2026) & (US$ Million)
- Table 7. Global Biomimetic Cryoprotectants Sales Market Share in Value by Type (2021-2026)
- Table 8. Global Biomimetic Cryoprotectants Price by Type (2021-2026) & (USD/L)
- Table 9. Global Biomimetic Cryoprotectants Sales by Type (2027-2032) & (L)
- Table 10. Global Biomimetic Cryoprotectants Sales Market Share in Volume by Type (2027-2032)
- Table 11. Global Biomimetic Cryoprotectants Sales by Type (2027-2032) & (US$ Million)
- Table 12. Global Biomimetic Cryoprotectants Sales Market Share in Value by Type (2027-2032)
- Table 13. Global Biomimetic Cryoprotectants Price by Type (2027-2032) & (USD/L)
- Table 14. North America Biomimetic Cryoprotectants Sales by Type (2021-2026) & (L)
- Table 15. North America Biomimetic Cryoprotectants Sales by Type (2021-2026) & (US$ Million)
- Table 16. Europe Biomimetic Cryoprotectants Sales by Type (2021-2026) & (L)
- Table 17. Europe Biomimetic Cryoprotectants Sales by Type (2021-2026) & (US$ Million)
- Table 18. Asia-Pacific Biomimetic Cryoprotectants Sales by Type (2021-2026) & (L)
- Table 19. Asia-Pacific Biomimetic Cryoprotectants Sales by Type (2021-2026) & (US$ Million)
- Table 20. Latin America Biomimetic Cryoprotectants Sales by Type (2021-2026) & (L)
- Table 21. Latin America Biomimetic Cryoprotectants Sales by Type (2021-2026) & (US$ Million)
- Table 22. Middle East and Africa Biomimetic Cryoprotectants Sales by Type (2021-2026) & (L)
- Table 23. Middle East and Africa Biomimetic Cryoprotectants Sales by Type (2021-2026) & (US$ Million)
- Table 24. Biomimetic Cryoprotectants Industry Trends
- Table 25. Biomimetic Cryoprotectants Industry Drivers
- Table 26. Biomimetic Cryoprotectants Industry Opportunities and Challenges
- Table 27. Biomimetic Cryoprotectants Industry Restraints
- Table 28. Global Biomimetic Cryoprotectants Sales Revenue by Company (US$ Million) & (2021-2026)
- Table 29. Global Biomimetic Cryoprotectants Revenue Market Share by Company (2021-2026)
- Table 30. Global Biomimetic Cryoprotectants Sales by Company (2021-2026) & (L)
- Table 31. Global Biomimetic Cryoprotectants Sales Share by Company (2021-2026)
- Table 32. Global Biomimetic Cryoprotectants Market Price by Company (2021-2026) & (USD/L)
- Table 33. Global Biomimetic Cryoprotectants Industry Company Ranking, 2024 VS 2025 VS 2026
- Table 34. Global Biomimetic Cryoprotectants Major Company Production Sites and Headquarters
- Table 35. Global Biomimetic Cryoprotectants Company, Product Type & Application
- Table 36. Global Biomimetic Cryoprotectants Company Establishment Date
- Table 37. Global Company Market Concentration Ratio (CR5 and HHI)
- Table 38. Global Biomimetic Cryoprotectants by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025)
- Table 39. Global Biomimetic Cryoprotectants Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032
- Table 40. Global Biomimetic Cryoprotectants Sales by Region (2021-2026) & (L)
- Table 41. Global Biomimetic Cryoprotectants Sales Market Share in Volume by Region (2021-2026)
- Table 42. Global Biomimetic Cryoprotectants Sales by Region (2021-2026) & (US$ Million)
- Table 43. Global Biomimetic Cryoprotectants Sales Market Share in Value by Region (2021-2026)
- Table 44. Global Biomimetic Cryoprotectants Sales (L), Value (US$ Million), Price (USD/L) and Gross Margin (2021-2026)
- Table 45. Global Biomimetic Cryoprotectants Sales by Region (2027-2032) & (L)
- Table 46. Global Biomimetic Cryoprotectants Sales Market Share in Volume by Region (2027-2032)
- Table 47. Global Biomimetic Cryoprotectants Sales by Region (2027-2032) & (US$ Million)
- Table 48. Global Biomimetic Cryoprotectants Sales Market Share in Value by Region (2027-2032)
- Table 49. Global Biomimetic Cryoprotectants Sales (L), Value (US$ Million), Price (USD/L) and Gross Margin (2027-2032)
- Table 50. Global Biomimetic Cryoprotectants Sales by Application (2021 VS 2025 VS 2032) & (US$ Million)
- Table 51. Global Biomimetic Cryoprotectants Sales by Application (2021-2026) & (L)
- Table 52. Global Biomimetic Cryoprotectants Sales Market Share in Volume by Application (2021-2026)
- Table 53. Global Biomimetic Cryoprotectants Sales by Application (2021-2026) & (US$ Million)
- Table 54. Global Biomimetic Cryoprotectants Sales Market Share in Value by Application (2021-2026)
- Table 55. Global Biomimetic Cryoprotectants Price by Application (2021-2026) & (USD/L)
- Table 56. Global Biomimetic Cryoprotectants Sales by Application (2027-2032) & (L)
- Table 57. Global Biomimetic Cryoprotectants Sales Market Share in Volume by Application (2027-2032)
- Table 58. Global Biomimetic Cryoprotectants Sales by Application (2027-2032) & (US$ Million)
- Table 59. Global Biomimetic Cryoprotectants Sales Market Share in Value by Application (2027-2032)
- Table 60. Global Biomimetic Cryoprotectants Price by Application (2027-2032) & (USD/L)
- Table 61. North America Biomimetic Cryoprotectants Sales by Application (2021-2026) & (L)
- Table 62. North America Biomimetic Cryoprotectants Sales by Application (2021-2026) & (US$ Million)
- Table 63. Europe Biomimetic Cryoprotectants Sales by Application (2021-2026) & (L)
- Table 64. Europe Biomimetic Cryoprotectants Sales by Application (2021-2026) & (US$ Million)
- Table 65. Asia-Pacific Biomimetic Cryoprotectants Sales by Application (2021-2026) & (L)
- Table 66. Asia-Pacific Biomimetic Cryoprotectants Sales by Application (2021-2026) & (US$ Million)
- Table 67. Latin America Biomimetic Cryoprotectants Sales by Application (2021-2026) & (L)
- Table 68. Latin America Biomimetic Cryoprotectants Sales by Application (2021-2026) & (US$ Million)
- Table 69. Middle East and Africa Biomimetic Cryoprotectants Sales by Application (2021-2026) & (L)
- Table 70. Middle East and Africa Biomimetic Cryoprotectants Sales by Application (2021-2026) & (US$ Million)
- Table 71. CellStore Biotechnology Company Information
- Table 72. CellStore Biotechnology Business Overview
- Table 73. CellStore Biotechnology Biomimetic Cryoprotectants Sales (L), Revenue (US$ Million), Price (USD/L) and Gross Margin (2021-2026)
- Table 74. CellStore Biotechnology Biomimetic Cryoprotectants Product Portfolio
- Table 75. CellStore Biotechnology Recent Development
- Table 76. X-Therma Company Information
- Table 77. X-Therma Business Overview
- Table 78. X-Therma Biomimetic Cryoprotectants Sales (L), Revenue (US$ Million), Price (USD/L) and Gross Margin (2021-2026)
- Table 79. X-Therma Biomimetic Cryoprotectants Product Portfolio
- Table 80. X-Therma Recent Development
- Table 81. Repligen Company Information
- Table 82. Repligen Business Overview
- Table 83. Repligen Biomimetic Cryoprotectants Sales (L), Revenue (US$ Million), Price (USD/L) and Gross Margin (2021-2026)
- Table 84. Repligen Biomimetic Cryoprotectants Product Portfolio
- Table 85. Repligen Recent Development
- Table 86. BMG Company Information
- Table 87. BMG Business Overview
- Table 88. BMG Biomimetic Cryoprotectants Sales (L), Revenue (US$ Million), Price (USD/L) and Gross Margin (2021-2026)
- Table 89. BMG Biomimetic Cryoprotectants Product Portfolio
- Table 90. BMG Recent Development
- Table 91. 21st Century Medicine Company Information
- Table 92. 21st Century Medicine Business Overview
- Table 93. 21st Century Medicine Biomimetic Cryoprotectants Sales (L), Revenue (US$ Million), Price (USD/L) and Gross Margin (2021-2026)
- Table 94. 21st Century Medicine Biomimetic Cryoprotectants Product Portfolio
- Table 95. 21st Century Medicine Recent Development
- Table 96. North America Biomimetic Cryoprotectants Market Size Growth Rate (CAGR) by Country (L): 2021 VS 2025 VS 2032
- Table 97. North America Biomimetic Cryoprotectants Sales by Country (2021-2026) & (L)
- Table 98. North America Biomimetic Cryoprotectants Sales Market Share by Country (2021-2026)
- Table 99. North America Biomimetic Cryoprotectants Sales Forecast by Country (2027-2032) & (L)
- Table 100. North America Biomimetic Cryoprotectants Sales Market Share Forecast by Country (2027-2032)
- Table 101. North America Biomimetic Cryoprotectants Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032
- Table 102. North America Biomimetic Cryoprotectants Market Size by Country (2021-2026) & (US$ Million)
- Table 103. North America Biomimetic Cryoprotectants Market Share by Country (2021-2026)
- Table 104. North America Biomimetic Cryoprotectants Market Size Forecast by Country (2027-2032) & (US$ Million)
- Table 105. North America Biomimetic Cryoprotectants Market Share Forecast by Country (2027-2032)
- Table 106. Europe Biomimetic Cryoprotectants Market Size Growth Rate (CAGR) by Country (L): 2021 VS 2025 VS 2032
- Table 107. Europe Biomimetic Cryoprotectants Sales by Country (2021-2026) & (L)
- Table 108. Europe Biomimetic Cryoprotectants Sales Market Share by Country (2021-2026)
- Table 109. Europe Biomimetic Cryoprotectants Sales Forecast by Country (2027-2032) & (L)
- Table 110. Europe Biomimetic Cryoprotectants Sales Market Share Forecast by Country (2027-2032)
- Table 111. Europe Biomimetic Cryoprotectants Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032
- Table 112. Europe Biomimetic Cryoprotectants Market Size by Country (2021-2026) & (US$ Million)
- Table 113. Europe Biomimetic Cryoprotectants Market Share by Country (2021-2026)
- Table 114. Europe Biomimetic Cryoprotectants Market Size Forecast by Country (2027-2032) & (US$ Million)
- Table 115. Europe Biomimetic Cryoprotectants Market Share Forecast by Country (2027-2032)
- Table 116. Asia-Pacific Biomimetic Cryoprotectants Market Size Growth Rate (CAGR) by Country (L): 2021 VS 2025 VS 2032
- Table 117. Asia-Pacific Biomimetic Cryoprotectants Sales by Country (2021-2026) & (L)
- Table 118. Asia-Pacific Biomimetic Cryoprotectants Sales Market Share by Country (2021-2026)
- Table 119. Asia-Pacific Biomimetic Cryoprotectants Sales Forecast by Country (2027-2032) & (L)
- Table 120. Asia-Pacific Biomimetic Cryoprotectants Sales Market Share Forecast by Country (2027-2032)
- Table 121. Asia-Pacific Biomimetic Cryoprotectants Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032
- Table 122. Asia-Pacific Biomimetic Cryoprotectants Market Size by Country (2021-2026) & (US$ Million)
- Table 123. Asia-Pacific Biomimetic Cryoprotectants Market Share by Country (2021-2026)
- Table 124. Asia-Pacific Biomimetic Cryoprotectants Market Size Forecast by Country (2027-2032) & (US$ Million)
- Table 125. Asia-Pacific Biomimetic Cryoprotectants Market Share Forecast by Country (2027-2032)
- Table 126. Latin America Biomimetic Cryoprotectants Market Size Growth Rate (CAGR) by Country (L): 2021 VS 2025 VS 2032
- Table 127. Latin America Biomimetic Cryoprotectants Sales by Country (2021-2026) & (L)
- Table 128. Latin America Biomimetic Cryoprotectants Sales Market Share by Country (2021-2026)
- Table 129. Latin America Biomimetic Cryoprotectants Sales Forecast by Country (2027-2032) & (L)
- Table 130. Latin America Biomimetic Cryoprotectants Sales Market Share Forecast by Country (2027-2032)
- Table 131. Latin America Biomimetic Cryoprotectants Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032
- Table 132. Latin America Biomimetic Cryoprotectants Market Size by Country (2021-2026) & (US$ Million)
- Table 133. Latin America Biomimetic Cryoprotectants Market Share by Country (2021-2026)
- Table 134. Latin America Biomimetic Cryoprotectants Market Size Forecast by Country (2027-2032) & (US$ Million)
- Table 135. Latin America Biomimetic Cryoprotectants Market Share Forecast by Country (2027-2032)
- Table 136. Middle East and Africa Biomimetic Cryoprotectants Market Size Growth Rate (CAGR) by Country (L): 2021 VS 2025 VS 2032
- Table 137. Middle East and Africa Biomimetic Cryoprotectants Sales by Country (2021-2026) & (L)
- Table 138. Middle East and Africa Biomimetic Cryoprotectants Sales Market Share by Country (2021-2026)
- Table 139. Middle East and Africa Biomimetic Cryoprotectants Sales Forecast by Country (2027-2032) & (L)
- Table 140. Middle East and Africa Biomimetic Cryoprotectants Sales Market Share Forecast by Country (2027-2032)
- Table 141. Middle East and Africa Biomimetic Cryoprotectants Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032
- Table 142. Middle East and Africa Biomimetic Cryoprotectants Market Size by Country (2021-2026) & (US$ Million)
- Table 143. Middle East and Africa Biomimetic Cryoprotectants Market Share by Country (2021-2026)
- Table 144. Middle East and Africa Biomimetic Cryoprotectants Market Size Forecast by Country (2027-2032) & (US$ Million)
- Table 145. Middle East and Africa Biomimetic Cryoprotectants Market Share Forecast by Country (2027-2032)
- Table 146. Key Raw Materials
- Table 147. Raw Materials Key Suppliers
- Table 148. Biomimetic Cryoprotectants Distributors List
- Table 149. Biomimetic Cryoprotectants Customers List
- Table 150. Research Programs/Design for This Report
- Table 151. Authors List of This Report
- Table 152. Secondary Sources
- Table 153. Primary Sources
List of Figures
- Figure 1. Biomimetic Cryoprotectants Image
- Figure 2. Global Biomimetic Cryoprotectants Market Size (US$ Million), 2021 VS 2025 VS 2032
- Figure 3. Global Biomimetic Cryoprotectants Market Size (2021-2032) & (US$ Million)
- Figure 4. Global Biomimetic Cryoprotectants Sales (2021-2032) & (L)
- Figure 5. Cryopreservation Media Image
- Figure 6. Global Cryopreservation Media Sales YoY Growth (2021-2032) & (L)
- Figure 7. Cryoprotectant Additives Image
- Figure 8. Global Cryoprotectant Additives Sales YoY Growth (2021-2032) & (L)
- Figure 9. Global Biomimetic Cryoprotectants Market Size Overview by Type (2021-2032) & (US$ Million)
- Figure 10. Global Biomimetic Cryoprotectants Market Share by Type 2025 VS 2032
- Figure 11. North America Biomimetic Cryoprotectants Sales Market Share in Volume by Type in 2025
- Figure 12. North America Biomimetic Cryoprotectants Sales Market Share in Value by Type in 2025
- Figure 13. Europe Biomimetic Cryoprotectants Sales Market Share in Volume by Type in 2025
- Figure 14. Europe Biomimetic Cryoprotectants Sales Market Share in Value by Type in 2025
- Figure 15. Asia-Pacific Biomimetic Cryoprotectants Sales Market Share in Volume by Type in 2025
- Figure 16. Asia-Pacific Biomimetic Cryoprotectants Sales Market Share in Value by Type in 2025
- Figure 17. Latin America Biomimetic Cryoprotectants Sales Market Share in Volume by Type in 2025
- Figure 18. Latin America Biomimetic Cryoprotectants Sales Market Share in Value by Type in 2025
- Figure 19. Middle East and Africa Biomimetic Cryoprotectants Sales Market Share in Volume by Type in 2025
- Figure 20. Middle East and Africa Biomimetic Cryoprotectants Sales Market Share in Value by Type in 2025
- Figure 21. Global Top 5 and 10 Biomimetic Cryoprotectants Players Market Share by Revenue in 2025
- Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025
- Figure 23. Cell Therapy Image
- Figure 24. Global Cell Therapy Sales YoY Growth (2021-2032) & (L)
- Figure 25. Research & Biobanking Image
- Figure 26. Global Research & Biobanking Sales YoY Growth (2021-2032) & (L)
- Figure 27. Assisted Reproduction Image
- Figure 28. Global Assisted Reproduction Sales YoY Growth (2021-2032) & (L)
- Figure 29. Tissue & Organ Preservation Image
- Figure 30. Global Tissue & Organ Preservation Sales YoY Growth (2021-2032) & (L)
- Figure 31. Livestock Breeding Image
- Figure 32. Global Livestock Breeding Sales YoY Growth (2021-2032) & (L)
- Figure 33. Global Biomimetic Cryoprotectants Market Size Overview by Application (2021-2032) & (US$ Million)
- Figure 34. Global Biomimetic Cryoprotectants Market Share by Application 2025 VS 2032
- Figure 35. North America Biomimetic Cryoprotectants Sales Market Share in Volume by Application in 2025
- Figure 36. North America Biomimetic Cryoprotectants Sales Market Share in Value by Application in 2025
- Figure 37. Europe Biomimetic Cryoprotectants Sales Market Share in Volume by Application in 2025
- Figure 38. Europe Biomimetic Cryoprotectants Sales Market Share in Value by Application in 2025
- Figure 39. Asia-Pacific Biomimetic Cryoprotectants Sales Market Share in Volume by Application in 2025
- Figure 40. Asia-Pacific Biomimetic Cryoprotectants Sales Market Share in Value by Application in 2025
- Figure 41. Latin America Biomimetic Cryoprotectants Sales Market Share in Volume by Application in 2025
- Figure 42. Latin America Biomimetic Cryoprotectants Sales Market Share in Value by Application in 2025
- Figure 43. Middle East and Africa Biomimetic Cryoprotectants Sales Market Share in Volume by Application in 2025
- Figure 44. Middle East and Africa Biomimetic Cryoprotectants Sales Market Share in Value by Application in 2025
- Figure 45. North America Biomimetic Cryoprotectants Sales by Country: 2021 VS 2025 VS 2032 (L)
- Figure 46. North America Biomimetic Cryoprotectants Sales Share by Country: 2021 VS 2025 VS 2032
- Figure 47. North America Biomimetic Cryoprotectants Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million)
- Figure 48. North America Biomimetic Cryoprotectants Market Share by Country: 2021 VS 2025 VS 2032
- Figure 49. Europe Biomimetic Cryoprotectants Sales by Country: 2021 VS 2025 VS 2032 (L)
- Figure 50. Europe Biomimetic Cryoprotectants Sales Share by Country: 2021 VS 2025 VS 2032
- Figure 51. Europe Biomimetic Cryoprotectants Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million)
- Figure 52. Europe Biomimetic Cryoprotectants Market Share by Country: 2021 VS 2025 VS 2032
- Figure 53. Asia-Pacific Biomimetic Cryoprotectants Sales by Country: 2021 VS 2025 VS 2032 (L)
- Figure 54. Asia-Pacific Biomimetic Cryoprotectants Sales Share by Country: 2021 VS 2025 VS 2032
- Figure 55. Asia-Pacific Biomimetic Cryoprotectants Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million)
- Figure 56. Asia-Pacific Biomimetic Cryoprotectants Market Share by Country: 2021 VS 2025 VS 2032
- Figure 57. Latin America Biomimetic Cryoprotectants Sales by Country: 2021 VS 2025 VS 2032 (L)
- Figure 58. Latin America Biomimetic Cryoprotectants Sales Share by Country: 2021 VS 2025 VS 2032
- Figure 59. Latin America Biomimetic Cryoprotectants Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million)
- Figure 60. Latin America Biomimetic Cryoprotectants Market Share by Country: 2021 VS 2025 VS 2032
- Figure 61. Middle East and Africa Biomimetic Cryoprotectants Sales by Country: 2021 VS 2025 VS 2032 (L)
- Figure 62. Middle East and Africa Biomimetic Cryoprotectants Sales Share by Country: 2021 VS 2025 VS 2032
- Figure 63. Middle East and Africa Biomimetic Cryoprotectants Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million)
- Figure 64. Middle East and Africa Biomimetic Cryoprotectants Market Share by Country: 2021 VS 2025 VS 2032
- Figure 65. Biomimetic Cryoprotectants Value Chain
- Figure 66. Key Raw Materials Price
- Figure 67. Manufacturing Cost Structure
- Figure 68. Biomimetic Cryoprotectants Production Mode & Process
- Figure 69. Direct Comparison with Distribution Share
- Figure 70. Distributors Profiles
- Figure 71. Years Considered
- Figure 72. Research Process
- Figure 73. Key Executives Interviewed
Scope & coverage.
By Type
- Cryopreservation Media
- Cryoprotectant Additives
By Application
- Cell Therapy
- Research & Biobanking
- Assisted Reproduction
- Tissue & Organ Preservation
- Livestock Breeding
Companies covered
- CellStore Biotechnology
- X-Therma
- Repligen
- BMG
- 21st Century Medicine
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Biomimetic Cryoprotectants Market Size Estimates and Forecasts (2021-2032)
- 1.2.2 Global Biomimetic Cryoprotectants Sales Estimates and Forecasts (2021-2032)
- 1.3 Biomimetic Cryoprotectants Market by Type
- 1.3.1 Cryopreservation Media
- 1.3.2 Cryoprotectant Additives
- 1.4 Global Biomimetic Cryoprotectants Market Size by Type
- 1.4.1 Global Biomimetic Cryoprotectants Market Size Overview by Type (2021-2032)
- 1.4.2 Global Biomimetic Cryoprotectants Historic Market Size Review by Type (2021-2026)
- 1.4.3 Global Biomimetic Cryoprotectants Forecasted Market Size by Type (2027-2032)
- 1.5 Key Regions Market Size by Type
- 1.5.1 North America Biomimetic Cryoprotectants Sales Breakdown by Type (2021-2026)
- 1.5.2 Europe Biomimetic Cryoprotectants Sales Breakdown by Type (2021-2026)
- 1.5.3 Asia-Pacific Biomimetic Cryoprotectants Sales Breakdown by Type (2021-2026)
- 1.5.4 South America Biomimetic Cryoprotectants Sales Breakdown by Type (2021-2026)
- 1.5.5 Middle East and Africa Biomimetic Cryoprotectants Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
- 2.1 Biomimetic Cryoprotectants Industry Trends
- 2.2 Biomimetic Cryoprotectants Industry Drivers
- 2.3 Biomimetic Cryoprotectants Industry Opportunities and Challenges
- 2.4 Biomimetic Cryoprotectants Industry Restraints
3 Market Competitive Landscape by Company
- 3.1 Global Top Players by Biomimetic Cryoprotectants Revenue (2021-2026)
- 3.2 Global Top Players by Biomimetic Cryoprotectants Sales (2021-2026)
- 3.3 Global Top Players by Biomimetic Cryoprotectants Price (2021-2026)
- 3.4 Global Biomimetic Cryoprotectants Industry Company Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Biomimetic Cryoprotectants Major Company Production Sites & Headquarters
- 3.6 Global Biomimetic Cryoprotectants Company, Product Type & Application
- 3.7 Global Biomimetic Cryoprotectants Company Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Biomimetic Cryoprotectants Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Biomimetic Cryoprotectants Players Market Share by Revenue in 2025
- 3.8.3 2025 Biomimetic Cryoprotectants Tier 1, Tier 2, and Tier 3
4 Biomimetic Cryoprotectants Regional Status and Outlook
- 4.1 Global Biomimetic Cryoprotectants Market Size and CAGR by Region: 2021 VS 2025 VS 2032
- 4.2 Global Biomimetic Cryoprotectants Historic Market Size by Region
- 4.2.1 Global Biomimetic Cryoprotectants Sales in Volume by Region (2021-2026)
- 4.2.2 Global Biomimetic Cryoprotectants Sales in Value by Region (2021-2026)
- 4.2.3 Global Biomimetic Cryoprotectants Sales (Volume & Value), Price and Gross Margin (2021-2026)
- 4.3 Global Biomimetic Cryoprotectants Forecasted Market Size by Region
- 4.3.1 Global Biomimetic Cryoprotectants Sales in Volume by Region (2027-2032)
- 4.3.2 Global Biomimetic Cryoprotectants Sales in Value by Region (2027-2032)
- 4.3.3 Global Biomimetic Cryoprotectants Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Biomimetic Cryoprotectants by Application
- 5.1 Biomimetic Cryoprotectants Market by Application
- 5.1.1 Cell Therapy
- 5.1.2 Research & Biobanking
- 5.1.3 Assisted Reproduction
- 5.1.4 Tissue & Organ Preservation
- 5.1.5 Livestock Breeding
- 5.2 Global Biomimetic Cryoprotectants Market Size by Application
- 5.2.1 Global Biomimetic Cryoprotectants Market Size Overview by Application (2021-2032)
- 5.2.2 Global Biomimetic Cryoprotectants Historic Market Size Review by Application (2021-2026)
- 5.2.3 Global Biomimetic Cryoprotectants Forecasted Market Size by Application (2027-2032)
- 5.3 Key Regions Market Size by Application
- 5.3.1 North America Biomimetic Cryoprotectants Sales Breakdown by Application (2021-2026)
- 5.3.2 Europe Biomimetic Cryoprotectants Sales Breakdown by Application (2021-2026)
- 5.3.3 Asia-Pacific Biomimetic Cryoprotectants Sales Breakdown by Application (2021-2026)
- 5.3.4 South America Biomimetic Cryoprotectants Sales Breakdown by Application (2021-2026)
- 5.3.5 Middle East and Africa Biomimetic Cryoprotectants Sales Breakdown by Application (2021-2026)
6 Company Profiles
- 6.1 CellStore Biotechnology
- 6.1.1 CellStore Biotechnology Company Information
- 6.1.2 CellStore Biotechnology Business Overview
- 6.1.3 CellStore Biotechnology Biomimetic Cryoprotectants Sales, Revenue and Gross Margin (2021-2026)
- 6.1.4 CellStore Biotechnology Biomimetic Cryoprotectants Product Portfolio
- 6.1.5 CellStore Biotechnology Recent Developments
- 6.2 X-Therma
- 6.2.1 X-Therma Company Information
- 6.2.2 X-Therma Business Overview
- 6.2.3 X-Therma Biomimetic Cryoprotectants Sales, Revenue and Gross Margin (2021-2026)
- 6.2.4 X-Therma Biomimetic Cryoprotectants Product Portfolio
- 6.2.5 X-Therma Recent Developments
- 6.3 Repligen
- 6.3.1 Repligen Company Information
- 6.3.2 Repligen Business Overview
- 6.3.3 Repligen Biomimetic Cryoprotectants Sales, Revenue and Gross Margin (2021-2026)
- 6.3.4 Repligen Biomimetic Cryoprotectants Product Portfolio
- 6.3.5 Repligen Recent Developments
- 6.4 BMG
- 6.4.1 BMG Company Information
- 6.4.2 BMG Business Overview
- 6.4.3 BMG Biomimetic Cryoprotectants Sales, Revenue and Gross Margin (2021-2026)
- 6.4.4 BMG Biomimetic Cryoprotectants Product Portfolio
- 6.4.5 BMG Recent Developments
- 6.5 21st Century Medicine
- 6.5.1 21st Century Medicine Company Information
- 6.5.2 21st Century Medicine Business Overview
- 6.5.3 21st Century Medicine Biomimetic Cryoprotectants Sales, Revenue and Gross Margin (2021-2026)
- 6.5.4 21st Century Medicine Biomimetic Cryoprotectants Product Portfolio
- 6.5.5 21st Century Medicine Recent Developments
7 North America by Country
- 7.1 North America Biomimetic Cryoprotectants Sales by Country
- 7.1.1 North America Biomimetic Cryoprotectants Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.1.2 North America Biomimetic Cryoprotectants Sales by Country (2021-2026)
- 7.1.3 North America Biomimetic Cryoprotectants Sales Forecast by Country (2027-2032)
- 7.2 North America Biomimetic Cryoprotectants Market Size by Country
- 7.2.1 North America Biomimetic Cryoprotectants Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2.2 North America Biomimetic Cryoprotectants Market Size by Country (2021-2026)
- 7.2.3 North America Biomimetic Cryoprotectants Market Size Forecast by Country (2027-2032)
8 Europe by Country
- 8.1 Europe Biomimetic Cryoprotectants Sales by Country
- 8.1.1 Europe Biomimetic Cryoprotectants Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.1.2 Europe Biomimetic Cryoprotectants Sales by Country (2021-2026)
- 8.1.3 Europe Biomimetic Cryoprotectants Sales Forecast by Country (2027-2032)
- 8.2 Europe Biomimetic Cryoprotectants Market Size by Country
- 8.2.1 Europe Biomimetic Cryoprotectants Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2.2 Europe Biomimetic Cryoprotectants Market Size by Country (2021-2026)
- 8.2.3 Europe Biomimetic Cryoprotectants Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
- 9.1 Asia-Pacific Biomimetic Cryoprotectants Sales by Country
- 9.1.1 Asia-Pacific Biomimetic Cryoprotectants Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.1.2 Asia-Pacific Biomimetic Cryoprotectants Sales by Country (2021-2026)
- 9.1.3 Asia-Pacific Biomimetic Cryoprotectants Sales Forecast by Country (2027-2032)
- 9.2 Asia-Pacific Biomimetic Cryoprotectants Market Size by Country
- 9.2.1 Asia-Pacific Biomimetic Cryoprotectants Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2.2 Asia-Pacific Biomimetic Cryoprotectants Market Size by Country (2021-2026)
- 9.2.3 Asia-Pacific Biomimetic Cryoprotectants Market Size Forecast by Country (2027-2032)
10 South America by Country
- 10.1 South America Biomimetic Cryoprotectants Sales by Country
- 10.1.1 South America Biomimetic Cryoprotectants Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.1.2 South America Biomimetic Cryoprotectants Sales by Country (2021-2026)
- 10.1.3 South America Biomimetic Cryoprotectants Sales Forecast by Country (2027-2032)
- 10.2 South America Biomimetic Cryoprotectants Market Size by Country
- 10.2.1 South America Biomimetic Cryoprotectants Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2.2 South America Biomimetic Cryoprotectants Market Size by Country (2021-2026)
- 10.2.3 South America Biomimetic Cryoprotectants Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
- 11.1 Middle East and Africa Biomimetic Cryoprotectants Sales by Country
- 11.1.1 Middle East and Africa Biomimetic Cryoprotectants Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.1.2 Middle East and Africa Biomimetic Cryoprotectants Sales by Country (2021-2026)
- 11.1.3 Middle East and Africa Biomimetic Cryoprotectants Sales Forecast by Country (2027-2032)
- 11.2 Middle East and Africa Biomimetic Cryoprotectants Market Size by Country
- 11.2.1 Middle East and Africa Biomimetic Cryoprotectants Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2.2 Middle East and Africa Biomimetic Cryoprotectants Market Size by Country (2021-2026)
- 11.2.3 Middle East and Africa Biomimetic Cryoprotectants Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
- 12.1 Biomimetic Cryoprotectants Value Chain Analysis
- 12.1.1 Biomimetic Cryoprotectants Key Raw Materials
- 12.1.2 Key Raw Materials Price
- 12.1.3 Raw Materials Key Suppliers
- 12.1.4 Manufacturing Cost Structure
- 12.1.5 Biomimetic Cryoprotectants Production Mode & Process
- 12.2 Biomimetic Cryoprotectants Sales Channels Analysis
- 12.2.1 Direct Comparison with Distribution Share
- 12.2.2 Biomimetic Cryoprotectants Distributors
- 12.2.3 Biomimetic Cryoprotectants Customers
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
- 14.6 Disclaimer
GET THE RESEARCH
Choose your license.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst